The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease

Bone Marrow Transplantation

Volumn 19, Issue 6, 1997, Pages 571-576

  Tanaka, J ^a   Imamura, M ^a   Kasai, M ^b   Hashino, S ^a   Kobayashi, S ^a   Noto, S ^a   Higa, T ^b   Sakurada, K ^a   Asaka, M ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO HOKUYU HOSPITAL   (Japan)

Author keywords

BMT; Cytokine; GVHD; PBSCT

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LYMPHOCYTIC LEUKEMIA; ALLOTRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030993920     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700708     Document Type: Article

References (35)

1. Ferrara JLM, Deeg HJ. Graft versus host disease. New Engl J Med 1991; 324: 667-674.
2. Antin JH, Ferrara JLM. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964-2968.
3. Ferrara JLM. Paradigm shift for graft-versus-host disease. Bone Marrow Transplant 1994; 14: 183-184.
4. Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061-2067.
5. McCarthy PL, Abhyankar S, Neben S et al. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood 1991; 78: 1915-1918.
6. Allen RD, Staley TA, Sidman CL. Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur J lmmunol 1993; 23: 333-337.
7. Garlisi CG, Pennline KJ, Smith SR et al. Cytokine gene expression in mice undergoing chronic graft-versus-host disease. Mol Immunol 1993; 30: 669-677.
8. Abhyankar S, Gilliland DG, Ferrara JLM. Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens. Transplantation 1993; 56: 1518-1523.
9. Tanaka J, Imamura M, Kasai M et al. Rapid analysis of tumor necrosis factor-alpha mRNA expression during veno-occlusive disease of the liver after allogeneic bone marrow transplantation. Transplantation 1993; 55: 430-432.
10. Tanaka J, Imamura M, Kasai M et al. Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 1993; 85: 558-565.
11. Tanaka J, Imamura M, Kasai M et al. Cytokine gene expression after allogeneic bone marrow transplantation. Leuk Lymphoma 1995; 16: 413-418.
12. Arai N, Nomura D, Villaret D et al. Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J Immunol 1989; 142: 274-282.
13. Vieira P, de Waal-Malefty R, Dang MN et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proc Natl Acad Sci USA 1991; 88: 1172-1176.
14. Minty A, Chalon P, Derocq JM et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248-250.
15. Wolf SF, Temple PA, Kobayashi M et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immmunol 1991; 146: 3074-3081.
16. Manetti R, Parronchi P, Giudizi M et al. Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 1993; 177: 1199-1204.
17. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84: 4008-4027.
18. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493-496.
19. Saiki R, Gelfand DJ, Stoffel S et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491.
20. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic b-actin gene: inter-species homology of sequences in the introns. Proc Natl Acad Sci USA 1985; 82: 6133-6137.
21. Mosmann TR, Cherwinski H, Bond MW et al. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357.
22. Salgame P, Abrams JS, Clayberger C et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279-282.
23. Spits H, Yssel H, Paliard X et al. IL-4 inhibits IL-2 mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. J Immunol 1989; 141: 29-36.
24. Lee HK, Xia X, Choi YS. IL-4 blocks the up-regulation of IL-2 receptors by IL-2 in normal human B cells. J Immunol 1990; 144: 3431-3436.
25. Malefty R, Abrams J, Bennett B et al. Interleukin 10 (IL-1O) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-1O produced by monocytes. J Exp Med 1991; 174: 1209-1220.
26. Fiorentino DF, Zlotnik A, Vieira P et al. IL-1O acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-3451.
27. Fowler DH, Kurasawa K, Husebekk A et al. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. J Immunol 1994; 152: 1004-1013.
28. Granelli-Piperno A. Lymphokine gene expression in vivo is inhibited by cyclosporin A. J Exp Med 1990; 171: 533-544.
29. Mehrotra PT, Wu D. Crim JM et al. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J Immunol 1993; 151: 2444-2452.
30. Russell NH, Hunter AE. Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 1994; 13: 353-355.
31. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
32. Koerbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
33. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
34. Tanaka J, Kasai M, Imamura M, Asaka M. Clinical application of allogeneic peripheral blood stem cells transplantation. Ann Hematol 1995; 71: 265-269.
35. Tanaka J, Imamura M, Zhu X et al. Potential benefit of rhG-CSF mobilized peripheral blood stem cells for allogeneic transplantation. Blood 1994; 84: 3595-3596.